NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsCRD summary
This review assessed the combined negative VIDAS D-dimer result and a non-high pre-test probability to exclude pulmonary embolism. The authors concluded that this method can safely and effectively exclude pulmonary embolism in outpatients with a suspected event. This was a largely well-conducted review, although a lack of clarity regarding study quality limited the interpretation of reliability.
Authors' objectives
To assess efficacy and safety of combined negative VIDAS D-dimer result with a non-high pre-test probability using Wells or Geneva models to exclude pulmonary embolism.
Searching
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and EBM Reviews were searched. Search dates spanned 1950 to 2008. Relevant journals and conference proceedings of International Society on Thrombosis and Haemostasis (2005 to 2007) were searched. Investigators and manufacturers were contacted and reference lists of included studies and reviews were scanned for other potentially relevant studies. There were no restrictions on language, publication type or year of publication.
Study selection
Studies of prospective consecutive patients with suspected pulmonary embolism diagnosed by pre-test probability and VIDAS D-dimer testing, and where anticoagulants or further testing were withheld when pulmonary embolism was excluded by these tests, were eligible for inclusion. Included studies had to have a minimum three-month follow-up. Studies that compared the intervention with a reference test were excluded. Primary outcomes of interest were pulmonary embolism-related death and sudden death that was possibly pulmonary embolism-related, and the rate of symptomatic venous thromboembolism (VTE) during the three-month follow-up. Symptomatic VTE was defined as a high probability V/Q (Ventilation/Perfusion) scan or computed tomography or pulmonary angiography with segmental intraluminal defects. Non-high pre-test probability was defined as unlikely using Wells' score or low/intermediate using Geneva score, Revised Geneva score or gestalt estimation. A negative D-dimer result was defined as less than 500ng/mL. Patients were largely emergency outpatients. Prevalence of pulmonary embolism was 20%.
Two independent reviewers selected studies for inclusion in the review. Discrepancies were resolved by discussion.
Assessment of study quality
Study quality assessment was carried out by two independent reviewers using the Newcastle-Ottawa Quality Assessment Scale. This covered selection and comparability of study groups and ascertainment of outcomes or exposure for cohort and case-control studies. The scale was adapted to include allocation concealment for assessment of randomised controlled trials (RCTs).
Discrepancies were resolved with the involvement of a third reviewer.
Data extraction
Data were extracted to enable the calculation of three-month thromboembolic risk, sensitivity, specificity, negative predictive value, negative likelihood ratio and 95% confidence intervals (CIs). Study authors were contacted for missing data where necessary.
Two reviewers independently extracted data. Disagreements were resolved with the involvement of a third reviewer.
Methods of synthesis
Studies were pooled in a statistical synthesis (method not reported). Heterogeneity was assessed using the I2 statistic. Sensitivity analysis was performed by adding in patients lost to follow-up.
Results of the review
Seven studies were included in the review (n=8,371): one RCT (n=1,693) and six prospective cohort management studies (n=6,678). Sample size ranged from 331 to 3,306 patients. Study quality was reported to be similar across included studies (detailed results not provided). Heterogeneity was reported to be low.
Diagnostic safety:
Three-month thromboembolic risk in patients untreated after a combined negative VIDAS D-dimer with a low/intermediate or unlikely pre-test probability of pulmonary embolism was three out of 2,166 patients (0.14%, 95% CI 0.05 to 0.41%). Sensitivity analysis increased this risk to 0.64% (95% CI 0.38 to 1.08%).
Diagnostic accuracy:
Overall results for combined non-high pre-test probability and negative D-dimer were: sensitivity 99.7% (95% CI 99.0% to 99.9%); specificity 47.4% (95% CI 46.0% to 48.9%); negative predictive value 99.9% (95%CI 99.6% to 100%); and negative likelihood ratio 0.01 (95% CI 0.00 to 0.02).
Sensitivity results were high for all combinations using any pre-test probability model (range 98.7% to 100%). Specificity ranged from 40.8% (low/intermediate pre-test probability) to 57.4% (unlikely pre-test probability).
In an analysis of six studies, the number of patients needed to be tested by VIDAS D-dimer to rule out one pulmonary embolism with no further investigations was 2.8 (95% CI 2.7 to 2.9).
Authors' conclusions
A negative VIDAS D-dimer combined with a non-high pre-test probability (defined as unlikely by Wells' model or low/intermediate by Geneva model or clinical gestalt) can safely and effectively exclude pulmonary embolism in outpatients with a suspected event.
CRD commentary
The review question was clear and supported by inclusion criteria that appeared to be potentially reproducible. The search strategy included a number of sources to locate published and unpublished material. Adequate attempts were made to minimise language and publication biases. The review process was conducted with sufficient attempts to minimise reviewer error and bias. An appropriate quality assessment tool was applied to included studies, but the results were not fully presented. Study details were presented. A statistical synthesis seemed appropriate in light of the authors' claim of low level heterogeneity. This was a largely well-conducted review, although a lack of clarity regarding study quality limited the interpretation of the reliability of findings.
Implications of the review for practice and research
Practice: The authors stated that the VIDAS D-dimer test could be used in all patients with suspected pulmonary embolism, regardless of their clinical probability.
Research: The authors did not state any implications for research.
Funding
Canadian Institute of Health Research. Heart and Stroke Foundation of Canada. University of Ottawa.
Bibliographic details
Carrier M, Righini M, Karami Djurabi R, Huisman MV, Perrier A, Wells PS, Rodger M, Wuillemin WA, Le Gal G. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism: a systematic review of management outcome studies. Thrombosis and Haemostasis 2009; 101(5): 886-892. [PubMed: 19404542]
Original Paper URL
Indexing Status
Subject indexing assigned by NLM
MeSH
Aged; Aged, 80 and over; Anticoagulants /therapeutic use; Biological Markers /blood; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products /analysis; Gestalt Theory; Health Status Indicators; Humans; Male; Predictive Value of Tests; Pulmonary Embolism /blood /diagnosis /drug therapy /etiology; Risk Assessment; Risk Factors; Sensitivity and Specificity
AccessionNumber
Database entry date
28/04/2010
Record Status
This is a critical abstract of a systematic review that meets the criteria for inclusion on DARE. Each critical abstract contains a brief summary of the review methods, results and conclusions followed by a detailed critical assessment on the reliability of the review and the conclusions drawn.
- CRD summary
- Authors' objectives
- Searching
- Study selection
- Assessment of study quality
- Data extraction
- Methods of synthesis
- Results of the review
- Authors' conclusions
- CRD commentary
- Implications of the review for practice and research
- Funding
- Bibliographic details
- Original Paper URL
- Indexing Status
- MeSH
- AccessionNumber
- Database entry date
- Record Status
- Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.[JAMA. 2014]Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, et al. JAMA. 2014 Mar 19; 311(11):1117-24.
- Review A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?[Int Angiol. 2005]Review A critical appraisal of non-invasive diagnosis and exclusion of deep vein thrombosis and pulmonary embolism in outpatients with suspected deep vein thrombosis or pulmonary embolism: how many tests do we need?Michiels JJ, Gadisseur A, Van Der Planken M, Schroyens W, De Maeseneer M, Hermsen JT, Trienekens PH, Hoogsteden H, Pattynama PM. Int Angiol. 2005 Mar; 24(1):27-39.
- Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule.[Ann Fam Med. 2016]Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule.Hendriksen JM, Lucassen WA, Erkens PM, Stoffers HE, van Weert HC, Büller HR, Hoes AW, Moons KG, Geersing GJ. Ann Fam Med. 2016 May; 14(3):227-34.
- Review Clinical decision rules for excluding pulmonary embolism: a meta-analysis.[Ann Intern Med. 2011]Review Clinical decision rules for excluding pulmonary embolism: a meta-analysis.Lucassen W, Geersing GJ, Erkens PM, Reitsma JB, Moons KG, Büller H, van Weert HC. Ann Intern Med. 2011 Oct 4; 155(7):448-60.
- Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability.[Thromb Res. 2006]Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability.Carrier M, Wells PS, Rodger MA. Thromb Res. 2006; 117(4):469-74.
- VIDAS D-dimer in combination with clinical pre-test probability to rule out pulm...VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism: a systematic review of management outcome studies - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...